Eric H. J. Duckers
Chief Executive Officer bei VST-Bio Corp.
Profil
Eric H.
J.
Duckers is currently the Chief Executive Officer & Director at VST-Bio Corp.
He previously worked as the Chief Medical Officer at BioCardia, Inc. and as the Chief Scientific Officer at Quorics BV.
From 2013 to 2016, he was the Head-Research & Development at the University Medical Center of Utrecht.
Dr. Duckers holds a doctorate degree from the University of Utrecht.
Aktive Positionen von Eric H. J. Duckers
| Unternehmen | Position | Beginn |
|---|---|---|
| VST-Bio Corp. | Chief Executive Officer | 01.05.2022 |
Ehemalige bekannte Positionen von Eric H. J. Duckers
| Unternehmen | Position | Ende |
|---|---|---|
| BIOCARDIA INC | Chief Tech/Sci/R&D Officer | 15.02.2021 |
| University Medical Center of Utrecht | Chief Tech/Sci/R&D Officer | 01.01.2016 |
BioCardia, Inc. /Old/
 BioCardia, Inc. /Old/ BiotechnologyHealth Technology BioCardia, Inc. is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The firm develops two comprehensive biotherapeutic products for cardiac arrest; CardiAMP and CardiALLO. CardiAMP is a bone marrow derived cell-based therapy for ischemic systolic heart failure patients who are not actively ischemic. CardiALLo is a allogeneic culture expanded mesenchymal bone marrow cells from a universal donor for use in multiple unrelated patients, entering Phase II development. Its other products also include Helix System and Morph Products. The company was founded in March 2002 and is headquartered in San Carlos, CA. | Chief Tech/Sci/R&D Officer | - |
Quorics BV
 Quorics BV BiotechnologyHealth Technology Quorics BV develops novel therapeutics and early diagnostic tests for cardiovascular diseases. The company was founded by Dharminder S. Chahal in 2012 and is headquartered in Rotterdam, the Netherlands. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Eric H. J. Duckers
| University of Utrecht | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIOCARDIA INC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
BioCardia, Inc. /Old/
BioCardia, Inc. /Old/ BiotechnologyHealth Technology BioCardia, Inc. is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The firm develops two comprehensive biotherapeutic products for cardiac arrest; CardiAMP and CardiALLO. CardiAMP is a bone marrow derived cell-based therapy for ischemic systolic heart failure patients who are not actively ischemic. CardiALLo is a allogeneic culture expanded mesenchymal bone marrow cells from a universal donor for use in multiple unrelated patients, entering Phase II development. Its other products also include Helix System and Morph Products. The company was founded in March 2002 and is headquartered in San Carlos, CA. | Health Technology |
Quorics BV
Quorics BV BiotechnologyHealth Technology Quorics BV develops novel therapeutics and early diagnostic tests for cardiovascular diseases. The company was founded by Dharminder S. Chahal in 2012 and is headquartered in Rotterdam, the Netherlands. | Health Technology |
| VST-Bio Corp. |
